RESULTS The observational study shows that majority of QoL domains in HNSCC patients
deteriorated during treatment but recovered after 1 month of the completion. Though there …

Results Sixty-five patients without recurrence were enrolled in this study. The mean
irradiated dose for bilateral parotids in the patients was 37.7 Gy. Median GOHAI scores …

The dominant pattern of spread and recurrence for head and neck squamous cell carcinoma
(HNSCC) is locoregional; therefore, surgery and radiation have historically played the …

Background: Concurrent chemoradiation (CRT) is now the standard organ preserving
approach for locally advanced head-neck squamous cell cancers (HNSCC). But for 7 weeks …

PURPOSE: To prospectively evaluate and compare health-related quality-of-life (QOL)
outcomes in patients with head–neck squamous cell carcinoma randomized to either …

Results 167 pts were identified, 133 treated with 3D-CRT and 34 who were treated with
IMRT. Disease was located in the supraglottis in 66 patients (39.5%), hypopharynx in 54 …

Purpose: To compare quality of life (QOL) and xerostomia between head-and-neck cancer
patients who received standard radiotherapy (RT) and patients matched by factors known to …

Results Patient's demographic characteristics, tumor factors and baseline characteristics in
QOL were comparable between the two arms. As expected, there was significant …

Objective The purpose of this study was to prospectively and longitudinally compare the
health-related quality of life (HRQOL) outcomes between head and neck (HN) cancer …

Results Of the 57 patients evaluated 35 (61%) received IMRT and 22 (39%) received HN-
SBRT. All patients (IMRT= 35, HN-SBRT= 22) completed the MDASI survey at baseline and …